GCM
PRAX icon

Graham Capital Management’s Praxis Precision Medicines PRAX Stock Holding History

Graham Capital Management’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-5,449
Closed -$206K – 1549
2025
Q1 		$206K Buy
5,449
+2,727
+100% +$170K ﹤0.01% 1126
2024
Q4 		$209K Buy
+2,722
New +$197K ﹤0.01% 1065
2022
Q4 		– Sell
-31,239
Closed -$1.06M – 1283
2022
Q3 		$1.06M Buy
31,239
+27,638
+768% +$1.38M 0.04% 459
2022
Q2 		$132K Buy
+3,601
New +$384K 0.01% 951

Other funds holding PRAX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Graham Capital Management's PRAX Position: Q2 2025 in Review

Graham Capital Management sold out of Praxis Precision Medicines (PRAX) in Q2 2025, closing a stake of 5,449 shares — an estimated $206K sold.

Graham Capital Management first reported a position in PRAX in Q2 2022 and held it in 4 quarters. The position peaked at $1.06M in Q3 2022. 143 funds tracked by Wall St. Rank hold PRAX as of Q2 2025.

  • Graham Capital Management reported no remaining Praxis Precision Medicines position as of Q2 2025 after selling out during the quarter.
  • Graham Capital Management sold 5,449 Praxis Precision Medicines shares in Q2 2025, an estimated $206K.
  • Graham Capital Management first reported a position in Praxis Precision Medicines in Q2 2022 and held it in 4 quarters.
  • Graham Capital Management's Praxis Precision Medicines position peaked at $1.06M in Q3 2022.
  • 143 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2025.

Based on Graham Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.